Piperazine-substituted benzothiophenes for treatment of mental disorders
US7888362B2 · kind B2 · utility
11Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2006 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Feb 23, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2059
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.